RecruitingPhase 4NCT06513208

Ketorolac Effects on Post-operative Pain and Lumbar Fusion

Ketorolac Effects on Post-operative Pain and Lumbar Fusion: a Double Blind Randomized Controlled Trial

Sponsor

University of Maryland St. Joseph Medical Center

Enrollment

140 participants

Start Date

Jan 1, 2026

Study Type

INTERVENTIONAL

Conditions

Lumbar Spinal Fusion

Summary

A double blind prospective randomized trial of IV ketorolac vs. placebo in management of patients undergoing lumbar one or two level spinal fusions.

Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Ketorolac Tromethamine and a drug called Placebo for people with lumbar spinal fusion. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 85 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGKetorolac Tromethamine

IV Ketorolac 15mg every 6 hours, x 4 doses

DRUGPlacebo

IV saline as placebo

Locations(1)

University of Maryland St. Joseph Medical Center

Towson, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06513208

Related Trials

Erector Spinae Plane Block in Lumbar Spinal Fusion

NCT049045751 location